Showing 1601-1610 of 10531 results for "".
Changing Approaches to Diagnosis and Research: DermTech's Contributions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/changing-approaches-to-diagnosis-and-research-dermtechs-contributions/20137/John Dobak, MD, President/CEO of DermTech discusses the addition of the company's melanoma test to the National Comprehensive Cancer Network guidelines. He talks about the future of clinical trials, especially the role of genomics for identifying trial participants and allowing more precise analysisFDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
https://practicaldermatology.com/series/dermwire-tv/fda-approves-eli-lillys-ad-drug-ebglyss-lebrikizumab/28645/In this week's DermwireTV, Andrew F. Alexis, MD, Professor of Clinical Dermatology at Weill Cornell Medical College, discusses the newly approved AD drug lebrikizumab; LEO Pharma announces two major regulatory milestones for its chronic hand eczema (CHE) treatment; and the CMO of Arcutis BioteherapuCOVID-19 Impact: iPledge and Isotretinoin Prescribing
https://practicaldermatology.com/topics/acne-rosacea/covid-19-impact-ipledge-and-isotretinoin-prescribing/19763/For patients on isotretinoin, complying with the iPledge program while treating patients virtually can be challenging. Joshua Zeichner, MD discusses new FDA guidance that allows female patients to take OTC pregnancy tests in order to continue treatment. He also discusses when patients do and do notNeuromodulators and Dermal Fillers: Dr. Gold
https://practicaldermatology.com/programs/practical-dermatology/neuromodulators-and-dermal-fillers-dr-gold/32694/Michael Gold, MD, talks about the new neurotoxins and applications, as well as fillers, that he covered during "Neuromodulators and Dermal Fillers: What's New, What's Coming and What Are We Doing That's New in 2025" at Maui Derm 2025.Currents: Skin Cancer Update
https://practicaldermatology.com/topics/skin-cancer-photoprotection/currents-skin-cancer-update/23259/Isotretinoin Online: Avoid Risk and Assure Safe Access
https://practicaldermatology.com/topics/practice-management/isotretinoin-online-avoid-risk-and-assure-safe-access/21441/Patients are buying the drug online without a prescription. Here's what dermatologists need to know to help protect patients and themselves.Body Dysmorphic Disorder Screening Tools for the Dermatologist: A Systematic Review
https://practicaldermatology.com/topics/general-topics/body-dysmorphic-disorder-screening-tools-for-the-dermatologist-a-systematic-review-s/21231/AI and Skin of Color: Hidden Biases Raise Questions
https://practicaldermatology.com/topics/skin-of-color/ai-and-skin-of-color-hidden-biases-raise-questions/23994/AI holds potential for practitioners, but it’s important to think critically about what data we use to build models.Step Up Your Approach to Fungal Infections
https://practicaldermatology.com/topics/general-topics/PD0709_03-php/22798/From choosing and using topical therapies to targeting onychomycosis, here are pointers for management of fungal diseases.Therapeutics Focus: Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/therapeutics-focus-skin-cancer/21419/New products and pharmacologic developments